CEO Links Gum Sales Boost to ‘Ozempic Breath’ as GLP-1 Use Rises
Hershey said Ice Breakers retail sales rose 8% last quarter as dental experts linked GLP-1 drugs to dry mouth and bad breath.
- On the company's earnings call last week, The Hershey Company CEO Kirk Tanner reported an 8% increase in Ice Breakers sales last quarter, attributing growth to "functional snacking tailwinds, including GLP-1 adoption."
- Demand for gum and mints appears linked to reports of "Ozempic breath" among users of GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro, who often report experiencing halitosis.
- While not an officially listed side effect, dental experts link the phenomenon to dry mouth, stating it is likely caused by dehydration and changes to saliva production from the medication.
- Swiss chocolatier Lindt and Magnum Ice Cream reported faster sales growth among people using these medications last year, showing other companies are experiencing similar trends.
- Hershey is not the only company known for sweet treats reporting a surprising lift in sales from GLP-1 users, suggesting a broader consumer shift within the functional snacking category.
20 Articles
20 Articles
Weight-Loss Medications Boost Mint and Gum Sales: Hershey Rides the ‘Ozempic Breath’ Wave
read the original version on: www.retailnews.asia The Hershey Company recently highlighted a surprising uptick in their sales of mints and gum, which they attribute to the rising prevalence of weight-loss drugs and the consequent shift in consumers’ snacking habits. The company noted that the demand for products that freshen breath has grown in tandem with the trends toward “functional snacking” associated […] The post Weight-Loss Medications Bo…
'Ozempic breath' sparks fresh demand for mints and gum
The Hershey Company has reported an “unexpected” lift in sales of mints and gum, as the growing use of weight-loss drugs appears to influence snacking habits. The company said demand for breath-freshening products has strengthened alongside “functional snacking” trends linked to the use of medications such as Ozempic and Wegovy. “We’ve also seen strong demand for gum and mints, as the category benefits from functional snacking tailwinds, includi…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
